comparemela.com

Page 8 - Lon Gsk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GSK s (GSK) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reiterated their buy rating on shares of GSK (LON:GSK – Get Rating) in a research note issued to investors on Tuesday morning, Marketbeat reports. Deutsche Bank Aktiengesellschaft currently has a GBX 1,700 ($21.01) target price on the stock. Several other analysts have also issued reports on the company. Shore Capital restated a […]

GSK plc (LON:GSK) Receives Average Rating of Hold from Brokerages

GSK plc (LON:GSK – Get Rating) has been given an average rating of “Hold” by the ten analysts that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating on the company. The average […]

GSK plc (LON:GSK) Given Consensus Rating of Hold by Brokerages

GSK plc (LON:GSK – Get Rating) has been given an average rating of “Hold” by the ten research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and three have issued a buy recommendation on the company. The average […]

GSK (LON:GSK) Earns Buy Rating from Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of GSK (LON:GSK – Get Rating) in a research note issued to investors on Tuesday, MarketBeat.com reports. They currently have a GBX 1,700 ($21.30) price target on the stock. A number of other research firms have also weighed in on GSK. Jefferies Financial Group set a […]

GSK s (GSK) Underweight Rating Reiterated at JPMorgan Chase & Co

JPMorgan Chase & Co. restated their underweight rating on shares of GSK (LON:GSK – Get Rating) in a report released on Tuesday morning, Marketbeat reports. Several other analysts have also recently commented on the company. Credit Suisse Group restated a neutral rating and set a GBX 1,510 ($19.05) target price on shares of GSK in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.